205 related articles for article (PubMed ID: 30809122)
1.
Villa C; Colombo G; Meneghini S; Gotti C; Moretti M; Ferini-Strambi L; Chisci E; Giovannoni R; Becchetti A; Combi R
Front Mol Neurosci; 2019; 12():17. PubMed ID: 30809122
[TBL] [Abstract][Full Text] [Related]
2. Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function.
Conti V; Aracri P; Chiti L; Brusco S; Mari F; Marini C; Albanese M; Marchi A; Liguori C; Placidi F; Romigi A; Becchetti A; Guerrini R
Neurology; 2015 Apr; 84(15):1520-8. PubMed ID: 25770198
[TBL] [Abstract][Full Text] [Related]
3. Exclusion of linkage of nine neuronal nicotinic acetylcholine receptor subunit genes expressed in brain in autosomal dominant nocturnal frontal lobe epilepsy in four unrelated families.
Bonati MT; Combi R; Asselta R; Duga S; Malcovati M; Oldani A; Zucconi M; Ferini-Strambi L; Dalprà L; Tenchini ML
J Neurol; 2002 Aug; 249(8):967-74. PubMed ID: 12195439
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation of the nicotinic acetylcholine receptor gene CHRNA4 in sporadic nocturnal frontal lobe epilepsy.
Chen Y; Wu L; Fang Y; He Z; Peng B; Shen Y; Xu Q
Epilepsy Res; 2009 Feb; 83(2-3):152-6. PubMed ID: 19058950
[TBL] [Abstract][Full Text] [Related]
5. Nicotinic Receptors in Sleep-Related Hypermotor Epilepsy: Pathophysiology and Pharmacology.
Becchetti A; Grandi LC; Colombo G; Meneghini S; Amadeo A
Brain Sci; 2020 Nov; 10(12):. PubMed ID: 33255633
[TBL] [Abstract][Full Text] [Related]
6. A major role of the nicotinic acetylcholine receptor gene CHRNA2 in autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is unlikely.
Gu W; Bertrand D; Steinlein OK
Neurosci Lett; 2007 Jul; 422(1):74-6. PubMed ID: 17602836
[TBL] [Abstract][Full Text] [Related]
7. Distinctive effects of nicotinic receptor intracellular-loop mutations associated with nocturnal frontal lobe epilepsy.
Weltzin MM; Lindstrom JM; Lukas RJ; Whiteaker P
Neuropharmacology; 2016 Mar; 102():158-73. PubMed ID: 26561946
[TBL] [Abstract][Full Text] [Related]
8. [Generation of epilepsy animal model bearing a genetic abnormality identified in autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) of humans].
Okada M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Feb; 30(1):9-14. PubMed ID: 20297737
[TBL] [Abstract][Full Text] [Related]
9. Further evidence of genetic heterogeneity in families with autosomal dominant nocturnal frontal lobe epilepsy.
De Marco EV; Gambardella A; Annesi F; Labate A; Carrideo S; Forabosco P; Civitelli D; Candiano IC; Tarantino P; Annesi G; Quattrone A
Epilepsy Res; 2007 Apr; 74(1):70-3. PubMed ID: 17324557
[TBL] [Abstract][Full Text] [Related]
10. The identification of a novel mutation of nicotinic acetylcholine receptor gene CHRNB2 in a Chinese patient: Its possible implication in non-familial nocturnal frontal lobe epilepsy.
Liu H; Lu C; Li Z; Zhou S; Li X; Ji L; Lu Q; Lv R; Wu L; Ma X
Epilepsy Res; 2011 Jun; 95(1-2):94-9. PubMed ID: 21497487
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of CHRNB2, CHRNA2 and CHRNA4 genes in Chinese population with autosomal dominant nocturnal frontal lobe epilepsy.
Chen Z; Wang L; Wang C; Chen Q; Zhai Q; Guo Y; Zhang Y
Int J Clin Exp Med; 2015; 8(6):9063-70. PubMed ID: 26309560
[TBL] [Abstract][Full Text] [Related]
12. Pleiotropic functional effects of the first epilepsy-associated mutation in the human CHRNA2 gene.
Hoda JC; Wanischeck M; Bertrand D; Steinlein OK
FEBS Lett; 2009 May; 583(10):1599-604. PubMed ID: 19383498
[TBL] [Abstract][Full Text] [Related]
13. Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry.
Indurthi DC; Qudah T; Liao VW; Ahring PK; Lewis TM; Balle T; Chebib M; Absalom NL
Pharmacol Res; 2019 Jan; 139():215-227. PubMed ID: 30472464
[TBL] [Abstract][Full Text] [Related]
14. The role of nicotinic acetylcholine receptors in autosomal dominant nocturnal frontal lobe epilepsy.
Becchetti A; Aracri P; Meneghini S; Brusco S; Amadeo A
Front Physiol; 2015; 6():22. PubMed ID: 25717303
[TBL] [Abstract][Full Text] [Related]
15. Human nocturnal frontal lobe epilepsy: pharmocogenomic profiles of pathogenic nicotinic acetylcholine receptor beta-subunit mutations outside the ion channel pore.
Hoda JC; Gu W; Friedli M; Phillips HA; Bertrand S; Antonarakis SE; Goudie D; Roberts R; Scheffer IE; Marini C; Patel J; Berkovic SF; Mulley JC; Steinlein OK; Bertrand D
Mol Pharmacol; 2008 Aug; 74(2):379-91. PubMed ID: 18456869
[TBL] [Abstract][Full Text] [Related]
16. Autosomal dominant nocturnal frontal lobe epilepsy with a mutation in the CHRNB2 gene.
Díaz-Otero F; Quesada M; Morales-Corraliza J; Martínez-Parra C; Gómez-Garre P; Serratosa JM
Epilepsia; 2008 Mar; 49(3):516-20. PubMed ID: 17900292
[TBL] [Abstract][Full Text] [Related]
17. Mutation Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy Reduces Low-Sensitivity α4β2, and Increases α5α4β2, Nicotinic Receptor Surface Expression.
Nichols WA; Henderson BJ; Marotta CB; Yu CY; Richards C; Dougherty DA; Lester HA; Cohen BN
PLoS One; 2016; 11(6):e0158032. PubMed ID: 27336596
[TBL] [Abstract][Full Text] [Related]
18. Mice expressing the ADNFLE valine 287 leucine mutation of the Β2 nicotinic acetylcholine receptor subunit display increased sensitivity to acute nicotine administration and altered presynaptic nicotinic receptor function.
O'Neill HC; Laverty DC; Patzlaff NE; Cohen BN; Fonck C; McKinney S; McIntosh JM; Lindstrom JM; Lester HA; Grady SR; Marks MJ
Pharmacol Biochem Behav; 2013 Jan; 103(3):603-21. PubMed ID: 23123803
[TBL] [Abstract][Full Text] [Related]
19. A signal peptide missense mutation associated with nicotine dependence alters α2*-nicotinic acetylcholine receptor function.
Dash B; Lukas RJ; Li MD
Neuropharmacology; 2014 Apr; 79():715-25. PubMed ID: 24467848
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
